EVALUATION OF COVID-19 VACCINES IN PRIMARY PREVENTION AGAINST INFECTIONS AND REDUCTION IN SEVERITY OF ILLNESS FOLLOWING THE OUTBREAK OF SARS-COV-2 OMICRON VARIANT IN SHANGHAI

被引：0
|
作者：
Yang, D. [1 ]
Weng, H. [2 ]
Song, Y. [1 ]
Li, J. [3 ]
Lu, X. [3 ]
Yang, W. [2 ]
Chen, Z. [4 ]
Xuan, J. [3 ]
Bai, C. [1 ]
Wang, Y. [5 ]
机构：
[1] Fudan Univ, Dept Pulm & Crit Care Med, Zhongshan Hosp, Shanghai, Peoples R China
[2] Suvalue Healthcare Sci Co Ltd, Shanghai, Peoples R China
[3] Shanghai Centennial Sci Co Ltd, Shanghai, Peoples R China
[4] Guangzhou Med Univ, Dept Clin Res Management Off, Affiliated Hosp 3, Guangzhou, Peoples R China
[5] Army Med Univ, Inst Surg Res, Daping Hosp,Wound Trauma Med Ctr, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH100
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [21] Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
    Qianqian Cui
    Zhengli Shi
    Duman Yimamaidi
    Ben Hu
    Zhuo Zhang
    Muhammad Saqib
    Ali Zohaib
    Baikadamova Gulnara
    Mukhanbetkaliyev Yersyn
    Zengyun Hu
    Shizhu Li
    Infectious Diseases of Poverty, 12
  • [22] Clinical Characteristics of COVID-19 Patients Infected by the Omicron Variant of SARS-CoV-2
    Zhang, Jianguo
    Chen, Nan
    Zhao, Daguo
    Zhang, Jinhui
    Hu, Zhenkui
    Tao, Zhimin
    FRONTIERS IN MEDICINE, 2022, 9
  • [23] Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
    Huang, Zhuoying
    Xu, Shuangfei
    Liu, Jiechen
    Wu, Linlin
    Qiu, Jing
    Wang, Nan
    Ren, Jia
    Li, Zhi
    Guo, Xiang
    Tao, Fangfang
    Chen, Jian
    Lu, Donglei
    Sun, Xiaodong
    Wang, Weibing
    BMC MEDICINE, 2022, 20 (01)
  • [24] Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
    Zhuoying Huang
    Shuangfei Xu
    Jiechen Liu
    Linlin Wu
    Jing Qiu
    Nan Wang
    Jia Ren
    Zhi Li
    Xiang Guo
    Fangfang Tao
    Jian Chen
    Donglei Lu
    Xiaodong Sun
    Weibing Wang
    BMC Medicine, 20
  • [25] Dynamic variations in COVID-19 with the SARS-CoV-2 Omicron variant in Kazakhstan and Pakistan
    Cui, Qianqian
    Shi, Zhengli
    Yimamaidi, Duman
    Hu, Ben
    Zhang, Zhuo
    Saqib, Muhammad
    Zohaib, Ali
    Gulnara, Baikadamova
    Yersyn, Mukhanbetkaliyev
    Hu, Zengyun
    Li, Shizhu
    INFECTIOUS DISEASES OF POVERTY, 2023, 12 (01)
  • [26] Hepatic dysfunctions in COVID-19 patients infected by the omicron variant of SARS-CoV-2
    Zhang, Jianguo
    Zhao, Daguo
    Hu, Jianhui
    Huang, Xing
    Gu, Qingqing
    Tao, Zhimin
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [27] SARS-CoV-2 Omicron (B.1.1.529) Variant: A Challenge with COVID-19
    Afshar, Zeinab Mohseni
    Pirzaman, Ali Tavakoli
    Karim, Bardia
    Anaraki, Shiva Rahimipour
    Hosseinzadeh, Rezvan
    Pireivatlou, Elaheh Sanjari
    Babazadeh, Arefeh
    Hosseinzadeh, Dariush
    Miri, Seyed Rouhollah
    Sio, Terence T.
    Sullman, Mark J. M.
    Barary, Mohammad
    Ebrahimpour, Soheil
    DIAGNOSTICS, 2023, 13 (03)
  • [28] COVID-19 vaccines efficacy in preventing or limiting SARS-CoV-2 infections
    Mattiuzzi, Camilla
    Lippi, Giuseppe
    JOURNAL OF INFECTION, 2022, 84 (05) : 726 - 727
  • [29] Drastic decline in sera neutralization against SARS-CoV-2 Omicron variant in Wuhan COVID-19 convalescents
    Ma, Chengbao
    Chen, Xianying
    Mei, Fanghua
    Xiong, Qing
    Liu, Qianyun
    Dong, Lianghui
    Liu, Chen
    Zou, Wenjing
    Zhan, Faxian
    Hu, Bing
    Liu, Yingle
    Liu, Fang
    Zhou, Li
    Xu, Junqiang
    Jiang, Yongzhong
    Xu, Ke
    Cai, Kun
    Chen, Yu
    Yan, Huan
    Lan, Ke
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 567 - 572
  • [30] SARS-CoV-2 Targets and COVID-19 Vaccines
    Currier, Arthur W.
    Jeshurin, Madeline C.
    Sampson, Valerie B.
    COVID, 2021, 1 (03): : 608 - 621
12345